Firebrick Pharma (ASX:FRE) founder and CEO Peter Molloy addressed investors this week around commercialisation of Nasodine, a nasal spray that kills cold and flu viruses without any potential for ...
and insulating firebrick both in China and internationally with a market cap of CN¥6.45 billion. Operations: Luyang Energy-Saving Materials Co., Ltd. generates its revenue through the production ...
DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results